Literature DB >> 1860334

Administration of angiotensin II in refractory septic shock.

V L Thomas1, M S Nielsen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1860334     DOI： 10.1097/00003246-199108000-00020

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  8 in total

1.  Sequential changes in the metabolic response in severely septic patients during the first 23 days after the onset of peritonitis.

Authors:  L D Plank; A B Connolly; G L Hill
Journal:  Ann Surg       Date:  1998-08       Impact factor: 12.969

2.  Vasopressors and Risk of Acute Mesenteric Ischemia: A Worldwide Pharmacovigilance Analysis and Comprehensive Literature Review.

Authors:  Mathieu Jozwiak; Guillaume Geri; Driss Laghlam; Kevin Boussion; Charles Dolladille; Lee S Nguyen
Journal:  Front Med (Lausanne)       Date:  2022-05-23

Review 3.  Angiotensin II in septic shock.

Authors:  Thiago D Corrêa; Jukka Takala; Stephan M Jakob
Journal:  Crit Care       Date:  2015-03-16       Impact factor: 9.097

Review 4.  The effect of angiotensin II on blood pressure in patients with circulatory shock: a structured review of the literature.

Authors:  Laurence W Busse; Michael T McCurdy; Osman Ali; Anna Hall; Huaizhen Chen; Marlies Ostermann
Journal:  Crit Care       Date:  2017-12-28       Impact factor: 9.097

Review 5.  Clinical Experience With IV Angiotensin II Administration: A Systematic Review of Safety.

Authors:  Laurence W Busse; Xueyuan Shelly Wang; Divya M Chalikonda; Kevin W Finkel; Ashish K Khanna; Harold M Szerlip; David Yoo; Sharon L Dana; Lakhmir S Chawla
Journal:  Crit Care Med       Date:  2017-08       Impact factor: 7.598

6.  Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II.

Authors:  James A Tumlin; Raghavan Murugan; Adam M Deane; Marlies Ostermann; Laurence W Busse; Kealy R Ham; Kianoush Kashani; Harold M Szerlip; John R Prowle; Azra Bihorac; Kevin W Finkel; Alexander Zarbock; Lui G Forni; Shannan J Lynch; Jeff Jensen; Stew Kroll; Lakhmir S Chawla; George F Tidmarsh; Rinaldo Bellomo
Journal:  Crit Care Med       Date:  2018-06       Impact factor: 7.598

7.  Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study.

Authors:  Lakhmir S Chawla; Laurence Busse; Ermira Brasha-Mitchell; Danielle Davison; Jacqueline Honiq; Ziyad Alotaibi; Michael G Seneff
Journal:  Crit Care       Date:  2014-10-06       Impact factor: 9.097

Review 8.  Angiotensin II: a new therapeutic option for vasodilatory shock.

Authors:  Rachel L Bussard; Laurence W Busse
Journal:  Ther Clin Risk Manag       Date:  2018-07-26       Impact factor: 2.423
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.